Hikma Pharmaceutical | HIK - Spese Operative

Prezzo Delle Azioni
1,264.50
Cambio Giornaliero
1.50 0.12%
Mensile
1.24%
Annuale
-35.58%
Q1 Previsione
1,233.89




Spese Operative Cambiamento Data
Almirall EUR 517.4M 32K 2025-12
argenx SE USD 914.57M 137.58M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Autolus Therapeutics Ltd USD 92.82M 10.21M 2025-09
Bayer EUR 10.33B 126M 2025-12
Fresenius EUR 5.25B 337M 2025-12
Galapagos EUR 120.26M 7.43M 2025-12
Genmab DKK 798M 235M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
GRIFOLS EUR 1.71B 193M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.78B 669M 2025-12
Orion EUR 367.1M 64.9M 2025-12
Recordati EUR 384.01M 82.67M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
UCB EUR 2.96B 196M 2025-12